Vanguard Capital Management’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
Other funds holding COCP
Vanguard Capital Management's COCP Position: Q3 2026 in Review
Vanguard Capital Management held its Cocrystal Pharma (COCP) position steady in Q3 2026 at 358,228 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #3700.
Vanguard Capital Management first reported a position in COCP in Q1 2026 and has held it in 3 quarters since. 25 funds tracked by Wall St. Rank hold COCP as of Q3 2026.
- Vanguard Capital Management held 358,228 shares of Cocrystal Pharma worth $412K as of Q3 2026.
- Vanguard Capital Management left its Cocrystal Pharma share count unchanged in Q3 2026.
- Cocrystal Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3700 holding.
- Vanguard Capital Management first reported a position in Cocrystal Pharma in Q1 2026 and has held it in 3 quarters since.
- 25 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.